Idiopátiás tüdőfibrózis: vizsgálatok itt: Kanada
12 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Ajax, Montreal, Québec, Toronto, Trois-Rivières, Vancouver, Windsor
- Életkor
- 40 év and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - 2. fázisTaking peopleAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Where
- Ajax, Montreal, Trois-Rivières, Vancouver
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT06951217 - 3. fázisNot yet taking people in KanadaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Burlington, Greenfield Park, Hamilton, Montreal, Owen Sound, Sherwood Park, Toronto, Trois-Rivières, Vancouver
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Ajax, Burlington, Kingston, North York, Saint-Charles-Borromée, Sherbrooke, Sherwood Park, Vancouver
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - 3. fázisTaking peopleTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Ajax, Windsor
- Életkor
- 40 év and over
- People
- 1100 worldwide
- Run by
- PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00 - 3. fázisCsak meghívásosExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Ajax, Hamilton, Québec, Toronto, Trois-Rivières, Vancouver
- Életkor
- 40 év and over
- People
- 1850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - 2. fázisTaking peopleAURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
- Where
- Ajax, Calgary, Halifax, Montreal, Sherbrooke, St. John's, Toronto, Trois-Rivières, Vancouver
- Életkor
- 40 év and over
- People
- 160 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00 - 2. fázisTaking peoplePhase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Windsor
- Életkor
- 40 év to 80 év
- People
- 153
- Run by
- Mannkind Corporation
See details and how to joinNCT07679893 - 2. fázisTaking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Trois-Rivières
- Életkor
- 40 év and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00 - No phaseTaking peoplePRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Vancouver
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329 - 3. fázisTaking peopleStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Where
- Ajax, Hamilton, Montreal, Québec, Saskatoon, Sherbrooke, Vancouver
- Életkor
- 18 év and over
- People
- 698 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00 - No phaseTaking peopleSkeletal Muscle Function in Interstitial Lung Disease
- Where
- Vancouver
- Életkor
- 40 év to 80 év
- People
- 40
- Run by
- University of British Columbia
See details and how to joinNCT03800017